Skip to content
DataLookout
Menu

NCT05722561

E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder

StatusRecruiting
PhasePhase 2
Primary completion (estimated)

At risk: Primary completion moved at least 3 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 11 versions: 11 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 15 words
    • Primary completion pushed from Nov 1, 2026 to Feb 10, 2027
    • Study completion pushed from Mar 1, 2027 to Apr 30, 2027
    • Secondary endpoints: details revised at 2 of 9 entries
  2. Minor Primary completion date: Feb 1, 2027 to Nov 1, 2026v10
  3. Minor Primary completion date: Nov 1, 2026 to Feb 1, 2027v9
  4. Minor Enrollment target: 350 to 302
    • Primary completion date: Nov 2026 to Nov 1, 2026
    • Study completion date: Mar 2027 to Mar 1, 2027
    v8
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 2024 to Aug 8, 2024
    • Site details revised at 2 of 2 sites
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Notable Start date: Mar 2024 to Jul 2024
    • Study sites: 1 to 2
    v6
  2. Notable Primary completion date: Jan 30, 2025 to Nov 2026
    • Study completion date: May 31, 2026 to Mar 2027
    • Start date: Feb 29, 2024 to Mar 2024
    v5
  3. Notable Start date: Sep 30, 2023 to Feb 29, 2024v4
  4. Notable Start date: May 30, 2023 to Sep 30, 2023v3
  5. Notable Start date: Mar 2023 to May 30, 2023
    • Primary completion date: Nov 2025 to Jan 30, 2025
    • Study completion date: Mar 2026 to May 31, 2026
    v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Percentage of Participants who Achieve 100% Reduction in Cigarettes Per Day (CPD) between Baseline and End of Intervention (Visit 5)
Timeframe: Up to Visit 5 (Day 56)

Secondary (9)

Percentage of Participants who Achieve 100% Reduction in CPD between Baseline and Month 6 Follow-Up
Percentage of Participants who Achieve 100% Reduction in CPD between End of Intervention (Visit 5) and Month 6 Follow-Up
Change from Baseline in Self-Reported CPD at End of Intervention (Visit 5)
Change from Baseline in Self-Reported CPD at Month 6
Change from Baseline in Health-Related Quality of Life (HRQOL) Survey Score at End of Intervention (Visit 5)
Show 4 moreShow less
Change from Baseline in Health-Related Quality of Life (HRQOL) Survey Score at Month 6 Follow-up
Number of Respiratory Symptoms Reported at Baseline
Number of Respiratory Symptoms Reported at End of Treatment (Visit 5)
Number of Respiratory Symptoms Reported at Month 6 Follow-up

Arms and interventions

Electronic CigaretteExperimental

Participants in the Electronic Cigarette (EC) arm will receive telehealth motivational counseling for 5 weeks plus the standardized research e-cigarette (SREC).

Nicotine Replacement TherapyActive comparator

Participants in the Nicotine Replacement Therapy (NRT) arm will receive telehealth motivational counseling plus combination NRT (patch and lozenge).

Behavioral: Telehealth Motivational Counseling

Drugs: Nicotine Replacement Product

Devices: National Institute on Drug Abuse (NIDA) Standardized Research Electronic Cigarette (SREC).

Sites

2 sites in 1 country